Biden DXM Bill Includes Age Limit, Bulk Ingredient Scheduling

The Consumer Healthcare Products Association backs Sen. Joe Biden's proposal to set a nationwide age limit on purchases of dextromethorphan-containing OTC drugs, but the group differs with the bill's approach to regulating bulk sales of raw DXM

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet